Value through Innovation18 April 2014

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

17.06.2011

New data confirm superior blood pressure reductions in diabetic patients treated with TWYNSTA® compared to amlodipine alone

- For NON-US and NON-UK Healthcare Media Only
16.06.2011

Boehringer Ingelheim and Zealand Pharma enter into a licence and collaboration agreement to advance novel compounds to treat Type-2 diabetes and obesity

15.06.2011

Boehringer Ingelheim/Pfizer position regarding the recent publication by Singh et. al., in British Medical Journal, June 15, 2011

- For non-US Healthcare Media
26.05.2011

Actress Jane Seymour's appeal generates over one million votes to help prevent atrial fibrillation-related strokes

- For non-UK and non-US media
12.05.2011

Metacam® now on the FEI "List of Detection Times"

03.05.2011

FDA approves linagliptin tablets for the treatment of type 2 diabetes

- EX US and UK. Medical Media Only.
15.04.2011

Dabigatran etexilate recommended for approval in atrial fibrillation for stroke prevention in Europe

- For NON-US Healthcare Media Only
05.04.2011

Boehringer Ingelheim maintains sales level/course set for the future: product pipeline well-filled

04.04.2011

Breakthrough therapy dabigatran provides consistent benefit across all atrial fibrillation types and stroke risk groups

- For NON-US Healthcare Media Only
02.04.2011

Boehringer Ingelheim’s lead hepatitis C compound moves into phase III – the first within the BI HCV portfolio

- Not for U.S. media
01.04.2011

Sustained viral response achieved in 83% of hepatitis C infected patients with new HCV protease inhibitor from Boehringer Ingelheim

- Not for U.S. media
31.03.2011

U.S. FDA approves once-daily Viramune® XR™ tablet for use in combination with other antiretroviral agents for treatment of HIV-1 infection in adults

- For non-U.S. medical media
25.03.2011

Boehringer Ingelheim finalizes acquisition of AMGEN’s Fremont facility in the USA

24.03.2011

Dabigatran etexilate is cost-effective for stroke prevention in atrial fibrillation, particularly in real-world clinical practice

- For NON-US and Canadian Healthcare Media Only
23.03.2011

The POET-COPD® study results demonstrate superiority of Spiriva® (tiotropium) over long-acting beta agonist salmeterol in reducing the risk for COPD exacerbations

- For medical media outside the USA and Canada
22.03.2011

Survey of people with atrial fibrillation and their doctors uncovers need for more education about the link between AF and stroke

22.03.2011

Actress Jane Seymour takes up the fight against common heart rhythm disorder, atrial fibrillation and its link to stroke

- For non-UK and non-US media only
17.03.2011

Mixing claim approved for Mycoplasma vaccine from Boehringer Ingelheim